Novel synergistic mechanism for sst2 somatostatin and TNFα receptors to induce apoptosis: Crosstalk between NF-κB and JNK pathways

Cell Death and Differentiation

Volumn 14, Issue 2, 2007, Pages 197-208

  Guillermet Guibert, J ^a   Saint Laurent, N ^a   Davenne, L ^a   Rochaix, P ^b   Cuvillier, O ^a   Culler, M D ^c   Pradayrol, L ^a   Buscail, L ^a   Susini, C ^a   Bousquet, C ^a  

^a INSERM   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c Biomeasure Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; SOMATOSTATIN RECEPTOR 2; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN 3T3; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MODELS, BIOLOGICAL; MOLECULAR MIMICRY; NF-KAPPA B; NIH 3T3 CELLS; PHOSPHORYLATION; RECEPTORS, SOMATOSTATIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; SOMATOSTATIN; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 33846246279     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401939     Document Type: Article

References (45)

1. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C. Opportunities in somatostatin research: Biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2003; 2: 999-1017.
2. Bousquet C, Guillermet J, Vernejoul F, Lahlou H, Buscail L, Susini C. Somatostatin receptors and regulation of cell proliferation. Dig Liver Dis 2004; 36 (Suppl 1): S2-S7.
3. Teijeiro R, Rios R, Costoya JA, Castro R, Bello JL, Devesa J et al. Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53. Cell Physiol Biochem 2002; 12: 31-38.
4. Thompson JS. Somatostatin analogue predisposes enterocytes to apoptosis. J Gastrointest Surg 1998; 2: 167-173.
5. Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 1996; 10: 1688-1696.
6. Pasquali D, Vassallo P, Esposito D, Bonavolonta G, Bellastella A, Sinisi AA. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol 2000; 25: 63-71.
7. Tompa A, Jakab MG, Major J, Idei M, Bocsi J, Mihalik R et al. The somatostatin analogue peptide TT-232 induces apoptosis and chromosome breakage in cultured human lymphocytes. Mutat Res 2000; 465: 61-68.
8. Lattuada D, Casnici C, Venuto A, Marelli O. The apoptotic effect of somatostatin analogue SMS 201-995 on human lymphocytes. J Neuroimmunol 2002; 133: 211-216.
9. Ferone D, Pivonello R, Van Hagen PM, Dalm VA, Lichtenauer-Kaligis EG, Waaijers M et al. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes. Am J Physiol Endocrinol Metab 2002; 283: E1056-E1066.
10. Guillermet J, Saint-Laurent N, Rochaix P, Cuvillier O, Levade T, Schally AV et al. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis. Proc Natl Acad Sci USA 2003; 100: 155-160. Epub 2002 Dec 18.
11. Rauly I, Saint-Laurent N, Delesque N, Buscail L, Esteve JP, Vaysse N et al. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells. J Clin Invest 1996; 97: 1874-1883.
12. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P et al. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 1994; 91: 2315-2319.
13. Margolin N, Raybuck SA, Wilson KP, Chen W, Fox T, Gu Y et al. Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases. J Biol Chem 1997; 272: 7223-7228.
14. Tulipano G, Soldi D, Bagnasco M, Culler MD, Taylor JE, Cocchi D et al. Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 2002; 143: 1218-1224.
15. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403-1408.
16. Bousquet C, Delesque N, Lopez F, Saint-Laurent N, Esteve JP, Bedecs K et al. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem 1998; 273: 7099-7106.
17. Ferjoux G, Lopez F, Esteve JP, Ferrand A, Vivier E, Vely F et al. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Mol Biol Cell 2003; 14: 3911-3928. Epub 2003 Jul 11.
18. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003; 22: 8961-8982.
19. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 1998; 273: 33508-33516.
20. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270: 14255-14258.
21. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 1995; 14: 2876-2883.
22. Lin A. Activation of the JNK signaling pathway: Breaking the brake on apoptosis. Bioessays 2003; 25: 17-24.
23. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681-13686.
24. Thangaraju M, Sharma K, Leber B, Andrews DW, Shen SH, Srikant CB. Regulation of acidification and apoptosis by SHP-1 and Bcl-2. J Biol Chem 1999; 274: 29549-29557.
25. Boer U, Fennekohl A, Puschel GP. Sensitization by interleukin-6 of rat hepatocytes to tumor necrosis factor alpha-induced apoptosis. J Hepatol 2003; 38: 728-735.
26. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C et al. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB. Nat Cell Biol 2001; 3: 409-416.
27. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000; 404: 892-897.
28. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell 1998; 1: 543-551.
29. Dumont A, Hehner SP, Hofmann TG, Ueffing M, Droge W, Schmitz ML. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene 1999; 18: 747-757.
30. Kitajima I, Soejima Y, Takasaki I, Beppu H, Tokioka T, Maruyama I. Ceramide-induced nuclear translocation of NF-kappaB is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone 1996; 19: 263-270.
31. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci USA 1997; 94: 7531-7536.
32. Li T, Southall MD, Yi Q, Pei Y, Lewis D, Al-Hassani M et al. The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem 2003; 278: 16614-16621. Epub 2003 Feb 24.
33. Khaled AR, Butfiloski EJ, Sobel ES, Schiffenbauer J. Functional consequences of the SHP-1 defect in motheaten viable mice: Role of NF-kappa B. Cell Immunol 1998; 185: 49-58.
34. Massa PT, Wu C. Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J Interferon Cytokine Res 1998; 18: 499-507.
35. Chen BC, Yu CC, Lei HC, Chang MS, Hsu MJ, Huang CL et al. Bradykinin B2 receptor mediates NF-κB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. J Immunol 2004; 173: 5219-5228.
36. Lahlou H, Saint-Laurent N, Esteve JP, Eychene A, Pradayrol L, Pyronnet S et al. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J Biol Chem 2003; 278: 39356-39371.
37. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001; 414: 308-313.
38. Reuther-Madrid JY, Kashatus D, Chen S, Li X, Westwick J, Davis RJ et al. The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol 2002; 22: 8175-8183.
39. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M et al. Inhibition of JNK activation through NF-kappaB target genes. Nature 2001; 414: 313-317.
40. Shi RX, Ong CN, Shen HM. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells. Oncogene 2004; 23: 7712-7721.
41. Javelaud D, Besancon F. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: A mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 2001; 20: 4365-4372.
42. Yuan ZQ, Feldman RI, Sun M, Olashaw NE, Coppola D, Sussman GE et al. Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells. J Biol Chem 2002; 277: 29973-29982. Epub 2002 Jun 4.
43. Takeba Y, Suzuki N, Takeno M, Asai T, Tsuboi S, Hoshino T et al. Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis. Arthritis Rheum 1997; 40: 2128-2138.
44. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999; 274: 5053-5060.
45. Auernhammer CJ, Bousquet C, Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 1999; 96: 6964-6969.